On the basis of an evaluation of clinical tissues of ovarian cancer cases, we observed overexpression of CDX2 in ovarian mucinous adenocarcinoma but only weak expression in other histological types, including serous adenocarcinoma, endometrioid adenocarcinoma, and clear cell carcinoma. The gene discussed is CDX2; the disease is clear cell adenocarcinoma.